2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Ewing Sarcoma in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamamoto, T | 1 |
Ohno, T | 1 |
Wakahara, K | 1 |
Nagano, A | 1 |
Kawai, G | 1 |
Saitou, M | 1 |
Takigami, I | 1 |
Matsuhashi, A | 1 |
Yamada, K | 1 |
Shimizu, K | 1 |
Lawlor, ER | 1 |
Scheel, C | 1 |
Irving, J | 1 |
Sorensen, PH | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Ewing Sarcoma
Article | Year |
---|---|
Simultaneous inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways augment the sensitivity to actinomycin D in Ewing sarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Butadienes; Cell | 2009 |
Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors.
Topics: Artificial Gene Fusion; Bone Neoplasms; Butadienes; Cell Adhesion; Cell Division; Chromones; DNA-Bin | 2002 |